Daiichi Sankyo begins oncology therapy trial for metastatic tumours
Daiichi Sankyo has dosed the first patient in a first-in-human global Phase I trial to evaluate a Glycoprotein-A Repetitions Predominant…
Latest News
-
12 hours
-
14 hours
-
15 hours
-
1 day
-
12 hours
-
14 hours
-
15 hours
-
1 day
Participant in AstraZeneca’s Brazilian Covid-19 trial dies
Brazilian health agency Anvisa has announced that a volunteer in the Brazilian trial of AstraZeneca and Oxford University’s investigational Covid-19…
Latest News
View More
Merck’s V114 induces immune response in pneumococcal disease trials
Merck (MSD) has reported positive results from the Phase III PNEU-PATH and PNEU-DAY trials of its investigational 15-valent pneumococcal conjugate vaccine, V114, against pneumococcal disease.…
Pfizer and BioNTech initiate trials of Covid-19 vaccine in Japan
Pfizer and BioNTech have begun combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against Covid-19 in Japan. The trials will…
Aptinyx reports positive data from Phase II trial of NYX-783 for PTSD
Biopharma firm Aptinyx has reported positive results from the first Phase II study of its new NMDA receptor modulator, NYX-783,…
MediPharm begins trial of cannabis-derived products for kidney disease
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of its cannabis-derived medical products and…
VelosBio doses first patient in Phase II solid tumour drug trial
Biopharmaceutical company VelosBio has dosed the first patient in a Phase II trial of investigational drug VLS-101 in patients with…
Chinese Covid-19 vaccine shows promising results in Phase I/II trial
A potential Covid-19 vaccine being developed by China National Biotech Group (CNBG) unit Beijing Institute of Biologic Products demonstrated to…
Latest Content
View More
NIH initiates immune modulators trial for Covid-19
The US National Institutes of Health (NIH) has initiated a Phase III ACTIV-1 Immune Modulators (IM) trial to assess the…
WHO’s Solidarity trial shows repurposed drugs for Covid-19 are ineffective
World Health Organization (WHO) has reported that interim data from the Solidarity Therapeutics Trial of remdesivir, hydroxychloroquine, lopinavir / ritonavir…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
How the Formedix Visual Define.xml Editor Gives You Faster Define
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…